CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4/A Shares withheld for taxes Chief Business Officer gave up 10,686 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,984 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 15,980 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Business Officer gave up 15,980 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 9,952 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 40,165 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 26,645 shares (to pay taxes)
- 4 Option exercise President and COO acquired 26,750 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 4,793 shares (option exercise)
- 4 Option exercise Director acquired 4,793 shares (option exercise)
- 4 Option exercise Director acquired 4,793 shares (option exercise)
- 4 Option exercise Director acquired 4,793 shares (option exercise)
- 4 Option exercise Director acquired 4,793 shares (option exercise)
- 4 Option exercise Director acquired 4,793 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO gave up 2,975 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 3,042 shares (to pay taxes)
Page 2 of 21 · 414 filings